The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Role of computer-aided drug design in modern drug discovery
Abstract
Drug discovery utilizes chemical biology and computational drug design approaches for the efficient identification and optimization of lead compounds. Chemical biology is mostly involved in the elucidation of the biological function of a target and the mechanism of action of a chemical modulator. On the other hand, computer-aided drug design makes use of the structural knowledge of either the target (structure-based) or known ligands with bioactivity (ligand-based) to facilitate the determination of promising candidate drugs. Various virtual screening techniques are now being used by both pharmaceutical companies and academic research groups to reduce the cost and time required for the discovery of a potent drug. Despite the rapid advances in these methods, continuous improvements are critical for future drug discovery tools. Advantages presented by structure-based and ligand-based drug design suggest that their complementary use, as well as their integration with experimental routines, has a powerful impact on rational drug design. In this article, we give an overview of the current computational drug design and their application in integrated rational drug development to aid in the progress of drug discovery research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Computer-aided drug design has helped expedite the development of small-molecule inhibitors.172,173”
From Chasing molecular glue degraders: screening approaches (2022) · cites this paper as [172]
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M., Smith, J., Kasson, P., van der Spoel, D., et al. (2013) · Bioinform. · doi:10.1093/bioinformatics/btt055 · Cited by 7,255
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Cited by
Sorted by citations
Items 401–500 of 763
Agarwal, B., Gaware, S., More, N., Shinde, R., Shivakumar, H. N., & Jagdale, S. K. (2026) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2026.01.007 · Cited by 8
Masum, M. H. U., Parvin, R., Lokman, S. M., Tasnim, Z., Alam, M. M., & Ferdous, J. (2025) · Computational and Structural Biotechnology Reports · doi:10.1016/j.csbr.2025.100042 · Cited by 5
Shuvo, M. I. M., Niaz, S. M. R., Jannat, S., Hossain, M. A., Mashhur, N., Ahmed, N., Sohel, M., Hasan, M. I., Ansari, S. A., Humayoo, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-22320-8 · Cited by 5
Saleem, F., Mehmood, R., Mehar, S., Khan, M. T., Khan, Z.-U.-D., Ashraf, M., Ali, M. S., Abdullah, I., Froeyen, M., Mirza, M. U., et al. (2019) · Antioxidants · doi:10.3390/antiox8070231 · Cited by 5
Present and future challenges in therapeutic designing using computational approaches
Prasad, S., Srivastava, A., Singh, N., Singh, H., Saluja, R., Kumar, A., Yadav, N., & Qidwai, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91172-6.00020-0 · Cited by 5
Experimental and computational studies on transition metals interaction with Leucine and Isoleucine
Hasan, M. M., Shahriar, I., Ali, M., Halim, M. A., & Ehsan, M. Q. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133862 · Cited by 5
Deng, J., Liu, X., Li, Y., Ni, S.-H., Sun, S., Ou-Yang, X.-L., Ye, X., Wang, L., & Lu, L. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115966 · Cited by 5
Shafiq, N., Jannat, A., Munir, H., Rashid, M., & Parveen, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2234993 · Cited by 5
Jabbar, Z. A., Mahdi, M. F., & Razik, B. M. A. (2023) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v23i4.1096 · Cited by 5
Machine learning method aided discovery of the fourth-generation EGFR inhibitors
Zhang, Y., & Li, Y. (2023) · New Journal of Chemistry · doi:10.1039/d3nj03204c · Cited by 5
Li, X., Shi, R., Yan, L., Chu, W., Sun, R., Zheng, B., Wang, S., Tan, H. F., Wang, X., & Gao, Y. (2023) · Natural Products and Bioprospecting · doi:10.1007/s13659-023-00421-z · Cited by 5
Alabbas, A. B. (2024) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2024.103960 · Cited by 5
Hằng, N. T., My, T. T. K., Anh, L. T. V., Anh, P. T. V., Anh, T. D. H., & Phuong, N. V. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10839-3 · Cited by 5
Liu, L., Xiu-ping, L., Fan, Z., Deng, J., Zhang, S. L., Zhang, L., & Zha, X. (2024) · Pest Management Science · doi:10.1002/ps.8347 · Cited by 5
Tong, J., Zhao, Y., Jin, Y., Hao, Z., Li, S., & Sun, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151494 · Cited by 5
Ao, S., Han, D., Sun, L., Wu, Y., Liu, S., & Huang, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.581668 · Cited by 5
Kandjani, O. J., Alizadeh, A. A., Moosavi‐Movahedi, A. A., Kheradmand, S. S., & Dastmalchi, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.141 · Cited by 5
Nassar, H., Abu‐Dahab, R., & Taha, M. O. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02812-8 · Cited by 5
Cardiovascular Drugs: an Insight of In Silico Drug Design Tools
Sarma, H., Upadhyaya, M., Gogoi, B., Phukan, M., Kashyap, P., Das, B., Devi, R., & Sharma, H. K. (2021) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-021-09587-w · Cited by 7
Chittrarasu, M., Ahamed, A. S., & Sivakumar, A. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i50b33438 · Cited by 5
Accelerating Molecular Dynamics Enrichments of High-Affinity Ligands for Proteins
Liu, C., Brini, E., & Dill, K. A. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00855 · Cited by 5
Zhou, Y., Overhulse, J. M., Dupper, N. J., Guo, Y., Kashemirov, B. A., Wei, K., Govin, J., Petosa, C., & McKenna, C. E. (2022) · Journal of Computational Chemistry · doi:10.1002/jcc.26997 · Cited by 4
Ameji, P. J., Uzairu, A., Shallangwa, G. A., & Uba, S. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00473-1 · Cited by 5
In Silico Laboratory: Tools for Similarity-Based Drug Discovery
Lešnik, S., & Konc, J. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0163-1_1 · Cited by 5
Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study
Pardali, V., Giannakopoulou, E., Balourdas, D.-I., Myrianthopoulos, V., Taylor, M. C., Šekutor, M., Mlinarić‐Majerski, K., Kelly, J. M., & Zoidis, G. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200210150127 · Cited by 5
Liu, Z., Xiao, L., Guo, Y., Nan, X., Wang, H., He, Y., Yu, Z., Tang, X., & Xiong, B. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26590 · Cited by 6
Soto‐Delgado, J., Rodríguez‐Núñez, Y. A., Guerra, C., Prent-Peñaloza, L., & Bacho, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209970 · Cited by 4
Eissa, I. H., Elkady, H., Elgammal, W. E., Mahdy, H. A., Husein, D. Z., Ibrahim, I. M., Abdullah, R., Alsfouk, A. A., Elkaeed, E. B., & Metwaly, A. M. (2025) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416526500225 · Cited by 4
Ilić, A., Zukic, S., Oljačić, S., Maran, U., Nikolic, K. M., & Popović-Nikolić, M. R. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020273 · Cited by 4
Shuvo, M. N., Arian, T. A., Fuad, F., Noman, M. H., Alam, M. N., Himel, M. K., & Shil, A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346271 · Cited by 4
Oljačić, S., Popovic-Nikolic, M., Filipić, B., Gagić, Ž., & Nikolic, K. M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266337668241025061804 · Cited by 5
Viana, J. D. O., Weber, K. C., da Cruz, L. E. G., Santos, R. D. O., Rocha, G. B., Jordão, A. K., & Barbosa, E. G. (2024) · ACS Omega · doi:10.1021/acsomega.4c06146 · Cited by 4
A Xanthine Derivative With Novel Heat Shock Protein 90‐Alpha Inhibitory and Senolytic Properties
Atlante, S., Cis, L., Pirolli, D., Zamperla, M. G., Barbi, V., Mai, A., Zwergel, C., Marcozzi, S., Giuliani, M. E., Bigossi, G., et al. (2025) · Aging Cell · doi:10.1111/acel.70047 · Cited by 4
Leveraging computer-aided drug design for the discovery of phytohormone analogs: A review
Guo, Y., Qanmber, G., Liu, Z., Yang, H., Li, J., Yang, Z., Li, Z., Yang, L., & Yang, L. (2025) · Plant Stress · doi:10.1016/j.stress.2025.100951 · Cited by 4
Bogdańska, B., Khyluk, D., & Matosiuk, D. (2025) · Molecules · doi:10.3390/molecules30204079 · Cited by 4
Cavity/Binding Site Prediction Approaches and Their Applications
Avashthi, H., Srivastava, A., & Singh, D. B. (2020) · Springer eBooks · doi:10.1007/978-981-15-6815-2_3 · Cited by 4
Banik, A., Ahmed, S. R., Marma, H., Sinha, S., Khan, M. M. R., & Miah, K. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100851 · Cited by 4
Computational Prediction of Drug Phenotypic Effects Based on Substructure-Phenotype Associations
Yang, J., Zhang, D., Cai, Y., Yu, K., Li, M., Liu, L., & Chen, X. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3155453 · Cited by 5
Computer-Aided Drug Design of Plant-Based Compounds
Bıçak, B., & Kecel‐Gunduz, S. (2022) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-7337-5.ch013 · Cited by 4
In Silico Discovery of Anticancer Peptides from Sanghuang
Liu, M., Lv, J., Chen, L., Li, W., & Han, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213682 · Cited by 4
Atiya, A., Alsayari, A., Muhsinah, A. B., Almaghaslah, D., Bilgrami, A. L., Abdulmonem, W. A., Alorfi, N. M., DasGupta, D., Ashraf, G. M., Shamsi, A., et al. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2143425 · Cited by 5
Shrestha, R. L. S., Parajuli, N., Neupane, P., Dhital, S., Maharjan, B., Shrestha, T., Bharati, S., Marasini, B. P., & Subin, J. A. (2024) · Turkish computational and theoretical chemistry/Turkish computational and theoretical chemistry : · doi:10.33435/tcandtc.1487560 · Cited by 4
Gifty, V., Jothy, V. B., & Ganesan, V. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.139357 · Cited by 4
Docking-Based Classification of SGLT2 Inhibitors
Mazoudji, A., & Ecker, G. F. (2025) · Molecules · doi:10.3390/molecules30102179 · Cited by 5
Persons, J. D., Khan, S. N., & Ishima, R. (2018) · Methods · doi:10.1016/j.ymeth.2018.04.005 · Cited by 4
Alizadeh, A. A., & Dastmalchi, S. (2020) · Current Computer - Aided Drug Design · doi:10.2174/1573409916666200217091456 · Cited by 4
Computer-Aided Drug Design for Cancer Therapy
Daina, A., Röhrig, U. F., & Zoete, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11670-8 · Cited by 4
Spahi, S., Mutlu, Ö., Sarıyer, E., Koçer, S., Ugurel, E., & Turgut‐Balik, D. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107398 · Cited by 3
CADD: Some Success Stories from Sanjeevini and the Way Forward
Singh, A., Shekhar, S., & Jayaram, B. (2021) · Springer eBooks · doi:10.1007/978-981-15-8936-2_1 · Cited by 4
Khalaf, N. B., Pham, S., Romeo, G., Abdelghany, S., Intagliata, S., Sedillo, P., Salerno, L., Gonzales, J., Fathallah, D. M., Perkins, D. J., et al. (2021) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-021-00374-w · Cited by 4
Quantitative Structure–Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads
Gandhi, A., Masand, V. H., Zaki, M. E. A., Al‐Hussain, S. A., Ghorbal, A. B., & Chapolikar, A. (2021) · Molecules · doi:10.3390/molecules26164795 · Cited by 4
Gandhi, A., Masand, V. H., Zaki, M. E. A., Al‐Hussain, S. A., Ghorbal, A. B., & Chapolikar, A. (2021) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2021.1971295 · Cited by 4
Rahaman, A., Almalki, A. A., Rafeeq, M. M., Akhtar, O., Anjum, F., Mashraqi, M. M., Sain, Z. M., Alzamami, A., Ahmad, V., Zeng, X., et al. (2021) · Molecules · doi:10.3390/molecules26216517 · Cited by 4
An Undergraduate Chemistry Lab Exploring Computational Cost and Accuracy: Methane Combustion Energy
Wolf, M. E., Norris, J. W., Fynewever, H., Turney, J. M., & Schaefer, H. F. (2022) · Journal of Chemical Education · doi:10.1021/acs.jchemed.1c01243 · Cited by 4
Edache, E. I. (2022) · Journal of Virology and Viral Diseases · doi:10.54289/jvvd2200106 · Cited by 4
Protein-Ligand Binding with Applications in Molecular Docking
Mishra, N., & Forouzesh, N. (2012) · Computational biology · doi:10.1007/978-3-031-05914-8_1 · Cited by 4
Lee, K.-G., Santos, A. R. M. P., Kang, Y. G., Chae, Y. J., Shah, M., Pirzada, R. H., Song, M., Kim, J., Choi, S., & Park, Y. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00766 · Cited by 4
Self-citationA Variational Ansatz for Taylorized Imaginary Time Evolution
Koch, M., Schaudt, O., Mogk, G., Mrziglod, T., Berg, H., & Beck, M. E. (2023) · ACS Omega · doi:10.1021/acsomega.3c01060 · Cited by 6
Molecular Docking in Drug Designing and Metabolism
Saikia, S., Puzari, M., & Chetia, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-2816-3_14 · Cited by 4
Development of novel ligands against SARS‐CoV‐2 Mpro enzyme: an in silico and in vitro Study
Kaboudi, N., Krüger, N., & Hamzeh‐Mivehroud, M. (2023) · Molecular Informatics · doi:10.1002/minf.202300120 · Cited by 4
Tripathi, R. S., & Kumar, P. (2023) · Integrative Biology · doi:10.1093/intbio/zyad012 · Cited by 4
Molecular Insights from Spectral and Computational Studies on Crystalline and Amorphous Telmisartan
Singh, M., Murugan, N. A., Kongsted, J., Zhan, P., Banerjee, U. C., & Poongavanam, V. (2024) · Crystal Growth & Design · doi:10.1021/acs.cgd.4c00608 · Cited by 4
Ziemska, J., Solecka, J., & Jarończyk, M. (2017) · Chemical Papers · doi:10.1007/s11696-017-0251-3 · Cited by 4
Sepehri, B., & Ghavami, R. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.10.079 · Cited by 4
Introduction of structural bioinformatics with respect to drug discovery
Arya, H., Coumar, M. S., & Bhatt, T. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821471-8.00001-5 · Cited by 4
Role of Bioinformatics in Early Drug Discovery: An Overview and Perspective
Swain, S. S., & Hussain, T. (2021) · doi:10.1002/9781119654803.ch3 · Cited by 4
De novo Molecular Design using Deep Learning
Nguyen‐Vo, T. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25044362 · Cited by 4
Quantum Computational Concepts and Approaches in Drug Discovery, Development and Delivery
Meenakshi, D. U., Kesavan, S. M., Francis, A. P., & Khan, S. A. (2024) · doi:10.1002/9781394159338.ch1 · Cited by 4
Pharmacophore Modeling in Drug Design
Ghosh, R., Roy, S., Rakshit, G., Singh, N. K., & Maiti, N. J. (2024) · Wiley eBooks · doi:10.1002/9781394249190.ch8 · Cited by 4
A Systematic Review of Bioinformatics' Influence on Drug Developments
Afrin, S., Jai Shanker Pillai, H. P., S, C. E. E., Viktor, P., Hafiz, M. A., Al-Aouadi, R. F. A., Mahedi, M., Mudhafar, M., Batra, H. S., Kondaveeti, S. B., et al. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00934 · Cited by 3
High-throughput computational screening for lead discovery and development
Shaik, N. S., & Balya, H. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.001 · Cited by 4
Wang, H., Zhang, Z., Zhang, G., Wen, M., & Lü, H. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101339 · Cited by 3
Sama‐ae, I., Muengthongon, P., Tohlaeh, A., Rukhachan, W., Kiattikul, P., Samaeng, F., Mitklin, A., Rahman, M. A., Tedasen, A., Kwankaew, P., et al. (2025) · Scientifica · doi:10.1155/sci5/8838031 · Cited by 4
From AI modelling to validation: A 10-day pipeline for potential lead compounds validation
Chen, B., Hu, Y., He, W., Guo, L., Liu, R., Li, J., Li, X., Wei, L., Gu, A., Yang, S., et al. (2025) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2025.106761 · Cited by 3
EasyDock 1.3: An Automated Pipeline for Molecular Docking
Minibaeva, G., Yap, V., & Полищук, П. Г. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01221 · Cited by 4
Development of New Molecules Through Molecular Docking
Jaiswal, C., Pant, K. K., Behera, R. K. S., Bhatt, R., & Chandra, V. (2023) · Springer eBooks · doi:10.1007/978-981-99-2816-3_22 · Cited by 3
Almansour, N. M. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.101751 · Cited by 3
Interaction of eight steroid derivatives with VEGFR-1 using a theoretical model
Maria, L., Figueroa-Valverde, L., Alvarez-Ramirez, M., Marcela, R., Mateu-Armad, M. V., & Regina, C.-C. (2024) · Brazilian Journal of Science · doi:10.14295/bjs.v3i3.523 · Cited by 3
Baothman, O. A. S., & Islam, M. R. (2024) · Molecular Simulation · doi:10.1080/08927022.2024.2333907 · Cited by 3
Guo, W., Zhang, B., Liu, M., Zhang, J., & Feng, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04098-4 · Cited by 3
Lee, H. Y., Elkamhawy, A., Al-Karmalawy, A. A., Nada, H., Giovannuzzi, S., Supuran, C. T., & Lee, K. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400069 · Cited by 3
Hoseinpoor, S., Ul‐Haq, Z., Tsatsakis, A. M., Ramu, R., & Rezaee, R. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2439043 · Cited by 3
Improved Machine Learning Predictions of EC50s Using Uncertainty Estimation from Dose–Response Data
Bellamy, H., Dickhaut, J., & King, R. D. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00249 · Cited by 3
Alsfouk, B. A. A., Elgammal, W. E., Elkady, H., Mahdy, H. A., Husein, D. Z., Soliman, O., Abuelkhir, A. A., Eissa, I. H., Elkaeed, E. B., & Metwaly, A. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04439-7 · Cited by 3
Halder, D., Khan, M. S., Sue, T., Ali, M., Jahan, U. M. S., Atiquzzaman, M., Khatun, M., Islam, M. K., Keya, R. B., Hasan, A., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110867 · Cited by 3
Bhayye, S. S., Brahmachari, G., Nayek, N., Roy, S., & Roy, K. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1606735 · Cited by 3
Fibroblast growth factor 2 is a druggable target against glioblastoma: A computational investigation
Siddique, R., Abideen, S. A., Nabi, G., Awan, F. M., Khan, S. N., Ullah, F., Khan, S., & Xue, M. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1071929 · Cited by 3
Olajide, M., Abdul-Hammed, M., Bello, I. A., Adedotun, I. O., & Afolabi, T. I. (2023) · Physical Sciences Reviews · doi:10.1515/psr-2022-0281 · Cited by 3
Free tools and databases in ligand and structure-based drug design
Chaurasia, P., Bhargav, A., & Ramachandran, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18638-7.00002-5 · Cited by 3
Computational Modeling of Kinase Inhibitors as Anti-Alzheimer Agents
De, P., & Roy, K. (2023) · Neuromethods · doi:10.1007/978-1-0716-3311-3_5 · Cited by 3
A computational approach to identify natural putative inhibitors to combat monkeypox
Kharwar, R., Bhatt, M., Patel, K., Patel, S., & Daxini, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15457-7.00025-3 · Cited by 3
Khattak, S. U., Iqbal, Z., Lutfullah, G., Ahmad, S., Alharbi, M., Alasmari, A. F., & Irfan, M. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2273435 · Cited by 3
Artificial Intelligence-Mediated Computer-Aided Design of Viral Gene Therapies
Daneshvar, A., & Lukianov, S. N. (2023) · GEN Biotechnology · doi:10.1089/genbio.2023.0014 · Cited by 3
Sharma, R., Gulati, A., & Chopra, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6472-7_2 · Cited by 4
Geng, Y., Liu, Y., Wang, M., Dong, X., Sun, X. H., Luo, Y., & Sun, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1320475 · Cited by 3
Graph Neural Networks for Drug Discovery: An Integrated Decision Support Pipeline
Bongini, P. (2023) · IEEE International Conference on Metrology for eXtended Reality, Artificial Intelligence and Neural Engineering (MetroXRAINE) · doi:10.1109/metroxraine58569.2023.10405789 · Cited by 3
Mswahili, M. E., Ndomba, G. E., Jo, K., & Jeong, Y.-S. (2024) · Applied Sciences · doi:10.3390/app14041472 · Cited by 4
A Concise Review on role of QSAR in Drug Design
Prema, V., Sivaramakrishnan, M., & Rabiya, M. (2023) · Asian Journal of Research in Chemistry · doi:10.52711/0974-4150.2023.00076 · Cited by 3
Thoe, E. S., Chia, Y. Y., Tang, Y.-Q., & Chamyuang, S. (2024) · The Natural Products Journal · doi:10.2174/0122103155294164240323134513 · Cited by 4
Rahman, F. I., Zulfa, P. O., Beočanin, A., Faisal, I. M., Louca, N., Carstoiu, M. I., & Zufry, H. (2024) · Narra X · doi:10.52225/narrax.v2i1.112 · Cited by 3
Metadata
- Authors
- Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S.
- Affiliations
- Ewha Womans University (KR)
- Corresponding author
- Choi, Sun
- Venue
- Archives of Pharmacal Research
- Published
- 2015-07-25
- Volume
- 38
- Issue
- 9
- Pages
- 1686-1701
- ISSN
- 0253-6269 (ISSN-L)
- 1976-3786
- OpenAlex
- W1854810044
- Cited by
- 762
- References
- 156
- Citations by year
- 2026: 65 · 2025: 80 · 2024: 109 · 2023: 146 · 2022: 105 · 2021: 96 · 2020: 60 · 2019: 41 · 2018: 31 · 2017: 15 · 2016: 10 · 2015: 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Archives of Pharmacal Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- The Ministry of Science, ICT & Future Planning (MSIP) and National Research Foundation of Korea (2011-0028885)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- computer-aided drug design, drug discovery, structure-based drug design, ligand-based drug design, virtual screening, chemical biology, lead optimization, rational drug design
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Drug Design, Computer-Aided Design, Protein Structure, Secondary, Protein Structure, Tertiary, Quantitative Structure-Activity Relationship, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review